Researchers uncover how liraglutide targets specific brain regions to suppress appetite and promote significant weight loss ...

It’s a brain disease,” a prominent obesity doctor explained on a “60 Minutes” episode about the drugs. “Obesity is disease” ...

A weight-maintaining hormone is essential for brain-signal transmission. New research is more closely linking obesity to ...

Australian researchers said that supervised diets with intermittent fasting were for children with serious health conditions, ...

Children living in low-income areas with limited food access during early childhood are at greater risk for higher BMI and ...

Novo Nordisk's shares fell nearly 5% on Friday after results from a Phase 2a trial of the Danish drugmaker's experimental ...

A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some ...

Obesity is a disease characterized by having excessive body fat, increasing a person’s risk for many serious health problems, ...

Unfortunately, too many insurers — including Medicare — still see obesity as a cosmetic issue instead of the disease that it ...

Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...

In this morning’s readout from Novo's phase 2 trial of monlunabant in 243 people with obesity and metabolic syndrome, it ...

Three scientists are honoured for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?